The Pharmaceutical Risk Assessment and Mitigation Act of 2024 requires the Department of Defense to provide a report and updated guidance on managing risks in its pharmaceutical supply chains. The report must detail current information about ingredients and materials used in...
Simple Explanation
The bill wants the Department of Defense to write a report about where they get the stuff for making medicines, especially from places that might not be safe. They need to make sure they listen to the FDA about what's good or bad and keep checking to stay safe.